Karan Kanhai

1PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 06, 2022
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease.

Frits van Rhee, Adam Rosenthal, Karan Kanhai

Pageof 1

Frequent Collaborators

1 joint publications

Rabecka Martin